Skip to main content
Log in

Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT in Germany: two sides of two different coins

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Schreiter NF, Brenner W, Nogami M, Buchert R, Huppertz A, Pape UF, et al. Cost comparison of (111)In-DTPA-octreotide scintigraphy and (68)Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours. Eur J Nucl Med Mol Imaging 2012;39(1):72–82.

    Article  PubMed  Google Scholar 

  2. Wong KK, Wynn EA, Myles J, Ackermann RJ, Frey KA, Avram AM. Comparison of single time-point [111-In] pentetreotide SPECT/CT with dual time-point imaging of neuroendocrine tumors. Clin Nucl Med 2011;36(1):25–31.

    Article  PubMed  Google Scholar 

  3. BGBl. I, 22 July 2009; p. 1990

  4. §2 No. 3, AMVHV, amendment I, BAnz, 6 August 2009, p. 2890

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Juri Ruf.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ruf, J. Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT in Germany: two sides of two different coins. Eur J Nucl Med Mol Imaging 39, 723–724 (2012). https://doi.org/10.1007/s00259-011-2010-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-011-2010-y

Keywords

Navigation